FDA Approves GABAPENTIN — QUALLENT PHARMACEUTICALS HEALTH LLC

Quallients Pharmaceutical Health LLC received FDA approval on October 6, 2011, for the oral Gabapentin application ANDA200651, reflecting continued market interest in this active ingredient. This clearance will likely increase supply and foster competition, facilitating market access and potentially lowering costs for U.S. consumers of this therapeutic.